Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

被引:536
作者
Elmen, Joacim [1 ]
Lindow, Morten [1 ]
Silahtaroglu, Asli [2 ]
Bak, Mads [2 ]
Christensen, Mette [2 ]
Lind-Thomsen, Allan [2 ]
Hedtjarn, Maj [1 ]
Hansen, Jens Bo [1 ]
Hansen, Henrik Frydenlund [1 ]
Straarup, Ellen Marie [1 ]
McCullagh, Keith [1 ]
Kearney, Phil [1 ]
Kauppinen, Sakari [1 ,2 ]
机构
[1] Santaris Pharma, DK-2970 Horsholm, Denmark
[2] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark
关键词
D O I
10.1093/nar/gkm1113
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNA-122 (miR-122) is an abundant liver-specific miRNA, implicated in fatty acid and cholesterol metabolism as well as hepatitis C viral replication. Here, we report that a systemically administered 16-nt, unconjugated LNA (locked nucleic acid)-antimiR oligonucleotide complementary to the 5 end of miR-122 leads to specific, dose-dependent silencing of miR-122 and shows no hepatotoxicity in mice. Antagonism of miR-122 is due to formation of stable heteroduplexes between the LNA-antimiR and miR-122 as detected by northern analysis. Fluorescence in situ hybridization demonstrated uptake of the LNA-antimiR in mouse liver cells, which was accompanied by markedly reduced hybridization signals for mature miR-122 in treated mice. Functional antagonism of miR-122 was inferred from a low cholesterol phenotype and de-repression within 24 h of 199 liver mRNAs showing significant enrichment for miR-122 seed matches in their 3 UTRs. Expression profiling extended to 3 weeks after the last LNA-antimiR dose revealed that most of the changes in liver gene expression were normalized to saline control levels coinciding with normalized miR-122 and plasma cholesterol levels. Combined, these data suggest that miRNA antagonists comprised of LNA are valuable tools for identifying miRNA targets in vivo and for studying the biological role of miRNAs and miRNA-associated gene-regulatory networks in a physiological context.
引用
收藏
页码:1153 / 1162
页数:10
相关论文
共 48 条
[1]   Sequence variants in SLITRK1 are associated with Tourette's syndrome [J].
Abelson, JF ;
Kwan, KY ;
O'Roak, BJ ;
Baek, DY ;
Stillman, AA ;
Morgan, TM ;
Mathews, CA ;
Pauls, DA ;
Rasin, MR ;
Gunel, M ;
Davis, NR ;
Ercan-Sencicek, AG ;
Guez, DH ;
Spertus, JA ;
Leckman, JF ;
Dure, LS ;
Kurlan, R ;
Singer, HS ;
Gilbert, DL ;
Farhi, A ;
Louvi, A ;
Lifton, RP ;
Sestan, N ;
State, MW .
SCIENCE, 2005, 310 (5746) :317-320
[2]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[3]   A comparison of normalization methods for high density oligonucleotide array data based on variance and bias [J].
Bolstad, BM ;
Irizarry, RA ;
Åstrand, M ;
Speed, TP .
BIOINFORMATICS, 2003, 19 (02) :185-193
[4]   Principles of MicroRNA-target recognition [J].
Brennecke, J ;
Stark, A ;
Russell, RB ;
Cohen, SM .
PLOS BIOLOGY, 2005, 3 (03) :404-418
[5]   MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells [J].
Chan, JA ;
Krichevsky, AM ;
Kosik, KS .
CANCER RESEARCH, 2005, 65 (14) :6029-6033
[6]   Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice [J].
Costinean, S ;
Zanesi, N ;
Pekarsky, Y ;
Tili, E ;
Volinia, S ;
Heerema, N ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (18) :7024-7029
[7]  
Crooke ST, 2000, METHOD ENZYMOL, V313, P3
[8]  
Crooke ST, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P1
[9]   The Ensembl automatic gene annotation system [J].
Curwen, V ;
Eyras, E ;
Andrews, TD ;
Clarke, L ;
Mongin, E ;
Searle, SMJ ;
Clamp, M .
GENOME RESEARCH, 2004, 14 (05) :942-950
[10]   Improved targeting of miRNA with antisense oligonucleotides [J].
Davis, Scott ;
Lollo, Bridget ;
Freier, Susan ;
Esau, Christine .
NUCLEIC ACIDS RESEARCH, 2006, 34 (08) :2294-2304